Conmed Corp (CNMD) Reports In-Line Q2 EPS; Guides Q3
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.93 +0.73%
Revenue Growth %: -0.9%
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: -0.9%
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $183.2 million versus the consensus estimate of $185.81 million.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
